Index
1 Market Overview
1.1 Product Overview and Scope of Mammalian Biopharmaceutical Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Mammalian Biopharmaceutical Service by Type
1.3.1 Overview: Global Mammalian Biopharmaceutical Service Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Mammalian Biopharmaceutical Service Consumption Value Market Share by Type in 2022
1.3.3 Cell Line Development
1.3.4 Analytical Testing
1.3.5 Technology Transfer
1.3.6 Formulation Development
1.3.7 Others
1.4 Global Mammalian Biopharmaceutical Service Market by Application
1.4.1 Overview: Global Mammalian Biopharmaceutical Service Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical
1.4.3 Contract Research Organizations (CROs)
1.4.4 Academic and Research Institutes
1.4.5 Biotechnology Companies
1.4.6 Government Agencies
1.5 Global Mammalian Biopharmaceutical Service Market Size & Forecast
1.6 Global Mammalian Biopharmaceutical Service Market Size and Forecast by Region
1.6.1 Global Mammalian Biopharmaceutical Service Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Mammalian Biopharmaceutical Service Market Size by Region, (2018-2029)
1.6.3 North America Mammalian Biopharmaceutical Service Market Size and Prospect (2018-2029)
1.6.4 Europe Mammalian Biopharmaceutical Service Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Mammalian Biopharmaceutical Service Market Size and Prospect (2018-2029)
1.6.6 South America Mammalian Biopharmaceutical Service Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Mammalian Biopharmaceutical Service Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Mammalian Biopharmaceutical Service Product and Solutions
2.1.4 Lonza Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Mammalian Biopharmaceutical Service Product and Solutions
2.2.4 Novartis Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Novartis Recent Developments and Future Plans
2.3 KBI Biopharma
2.3.1 KBI Biopharma Details
2.3.2 KBI Biopharma Major Business
2.3.3 KBI Biopharma Mammalian Biopharmaceutical Service Product and Solutions
2.3.4 KBI Biopharma Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 KBI Biopharma Recent Developments and Future Plans
2.4 3P Biopharmaceuticals
2.4.1 3P Biopharmaceuticals Details
2.4.2 3P Biopharmaceuticals Major Business
2.4.3 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Product and Solutions
2.4.4 3P Biopharmaceuticals Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 3P Biopharmaceuticals Recent Developments and Future Plans
2.5 Sartorius Stedim Biotech
2.5.1 Sartorius Stedim Biotech Details
2.5.2 Sartorius Stedim Biotech Major Business
2.5.3 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Product and Solutions
2.5.4 Sartorius Stedim Biotech Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sartorius Stedim Biotech Recent Developments and Future Plans
2.6 Merck Millipore
2.6.1 Merck Millipore Details
2.6.2 Merck Millipore Major Business
2.6.3 Merck Millipore Mammalian Biopharmaceutical Service Product and Solutions
2.6.4 Merck Millipore Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Millipore Recent Developments and Future Plans
2.7 AGC Biologics
2.7.1 AGC Biologics Details
2.7.2 AGC Biologics Major Business
2.7.3 AGC Biologics Mammalian Biopharmaceutical Service Product and Solutions
2.7.4 AGC Biologics Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AGC Biologics Recent Developments and Future Plans
2.8 Rentschler Biopharma SE
2.8.1 Rentschler Biopharma SE Details
2.8.2 Rentschler Biopharma SE Major Business
2.8.3 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Product and Solutions
2.8.4 Rentschler Biopharma SE Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Rentschler Biopharma SE Recent Developments and Future Plans
2.9 Northway Biotech
2.9.1 Northway Biotech Details
2.9.2 Northway Biotech Major Business
2.9.3 Northway Biotech Mammalian Biopharmaceutical Service Product and Solutions
2.9.4 Northway Biotech Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Northway Biotech Recent Developments and Future Plans
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business
2.10.3 Boehringer Ingelheim Mammalian Biopharmaceutical Service Product and Solutions
2.10.4 Boehringer Ingelheim Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Boehringer Ingelheim Recent Developments and Future Plans
2.11 AGC
2.11.1 AGC Details
2.11.2 AGC Major Business
2.11.3 AGC Mammalian Biopharmaceutical Service Product and Solutions
2.11.4 AGC Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 AGC Recent Developments and Future Plans
2.12 Cambrex
2.12.1 Cambrex Details
2.12.2 Cambrex Major Business
2.12.3 Cambrex Mammalian Biopharmaceutical Service Product and Solutions
2.12.4 Cambrex Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cambrex Recent Developments and Future Plans
2.13 Samsung Biologics
2.13.1 Samsung Biologics Details
2.13.2 Samsung Biologics Major Business
2.13.3 Samsung Biologics Mammalian Biopharmaceutical Service Product and Solutions
2.13.4 Samsung Biologics Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Samsung Biologics Recent Developments and Future Plans
2.14 FUJIFILM Diosynth Biotechnologies
2.14.1 FUJIFILM Diosynth Biotechnologies Details
2.14.2 FUJIFILM Diosynth Biotechnologies Major Business
2.14.3 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Product and Solutions
2.14.4 FUJIFILM Diosynth Biotechnologies Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.15 GBI
2.15.1 GBI Details
2.15.2 GBI Major Business
2.15.3 GBI Mammalian Biopharmaceutical Service Product and Solutions
2.15.4 GBI Mammalian Biopharmaceutical Service Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 GBI Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Mammalian Biopharmaceutical Service Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Mammalian Biopharmaceutical Service by Company Revenue
3.2.2 Top 3 Mammalian Biopharmaceutical Service Players Market Share in 2022
3.2.3 Top 6 Mammalian Biopharmaceutical Service Players Market Share in 2022
3.3 Mammalian Biopharmaceutical Service Market: Overall Company Footprint Analysis
3.3.1 Mammalian Biopharmaceutical Service Market: Region Footprint
3.3.2 Mammalian Biopharmaceutical Service Market: Company Product Type Footprint
3.3.3 Mammalian Biopharmaceutical Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Mammalian Biopharmaceutical Service Consumption Value and Market Share by Type (2018-2023)
4.2 Global Mammalian Biopharmaceutical Service Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Mammalian Biopharmaceutical Service Consumption Value Market Share by Application (2018-2023)
5.2 Global Mammalian Biopharmaceutical Service Market Forecast by Application (2024-2029)
6 North America
6.1 North America Mammalian Biopharmaceutical Service Consumption Value by Type (2018-2029)
6.2 North America Mammalian Biopharmaceutical Service Consumption Value by Application (2018-2029)
6.3 North America Mammalian Biopharmaceutical Service Market Size by Country
6.3.1 North America Mammalian Biopharmaceutical Service Consumption Value by Country (2018-2029)
6.3.2 United States Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
6.3.3 Canada Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
6.3.4 Mexico Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Mammalian Biopharmaceutical Service Consumption Value by Type (2018-2029)
7.2 Europe Mammalian Biopharmaceutical Service Consumption Value by Application (2018-2029)
7.3 Europe Mammalian Biopharmaceutical Service Market Size by Country
7.3.1 Europe Mammalian Biopharmaceutical Service Consumption Value by Country (2018-2029)
7.3.2 Germany Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
7.3.3 France Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
7.3.5 Russia Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
7.3.6 Italy Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Mammalian Biopharmaceutical Service Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Mammalian Biopharmaceutical Service Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Mammalian Biopharmaceutical Service Market Size by Region
8.3.1 Asia-Pacific Mammalian Biopharmaceutical Service Consumption Value by Region (2018-2029)
8.3.2 China Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8.3.3 Japan Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8.3.4 South Korea Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8.3.5 India Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
8.3.7 Australia Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
9 South America
9.1 South America Mammalian Biopharmaceutical Service Consumption Value by Type (2018-2029)
9.2 South America Mammalian Biopharmaceutical Service Consumption Value by Application (2018-2029)
9.3 South America Mammalian Biopharmaceutical Service Market Size by Country
9.3.1 South America Mammalian Biopharmaceutical Service Consumption Value by Country (2018-2029)
9.3.2 Brazil Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
9.3.3 Argentina Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Mammalian Biopharmaceutical Service Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Mammalian Biopharmaceutical Service Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Mammalian Biopharmaceutical Service Market Size by Country
10.3.1 Middle East & Africa Mammalian Biopharmaceutical Service Consumption Value by Country (2018-2029)
10.3.2 Turkey Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
10.3.4 UAE Mammalian Biopharmaceutical Service Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Mammalian Biopharmaceutical Service Market Drivers
11.2 Mammalian Biopharmaceutical Service Market Restraints
11.3 Mammalian Biopharmaceutical Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Mammalian Biopharmaceutical Service Industry Chain
12.2 Mammalian Biopharmaceutical Service Upstream Analysis
12.3 Mammalian Biopharmaceutical Service Midstream Analysis
12.4 Mammalian Biopharmaceutical Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer